| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 31.820 | 17.941 | 29.062 | 40.284 | 42.398 | 53.123 | 78.470 | 30.711 | 0 |
| Total Income - EUR | - | 31.861 | 17.941 | 29.062 | 40.284 | 42.398 | 54.943 | 78.935 | 36.311 | 103 |
| Total Expenses - EUR | - | 11.977 | 7.132 | 8.190 | 7.891 | 12.883 | 11.640 | 20.793 | 22.862 | 0 |
| Gross Profit/Loss - EUR | - | 19.884 | 10.809 | 20.872 | 32.393 | 29.515 | 43.302 | 58.142 | 13.450 | 103 |
| Net Profit/Loss - EUR | - | 18.928 | 10.271 | 20.010 | 31.185 | 28.328 | 41.687 | 57.080 | 13.142 | 103 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Mascaş Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.967 | 1.767 | 6.507 | 5.034 | 3.883 | 1.727 | 2.600 | 0 | 0 |
| Current Assets | - | 18.284 | 27.250 | 43.095 | 74.585 | 102.664 | 40.973 | 56.186 | 14.887 | 151 |
| Inventories | - | 0 | 0 | 97 | 95 | 392 | 1.292 | 0 | 78 | 77 |
| Receivables | - | 17.769 | 9.769 | 2.559 | 2.817 | 1.374 | 2.465 | 42.488 | 7.392 | 74 |
| Cash | - | 515 | 17.480 | 40.438 | 71.672 | 100.899 | 37.216 | 13.698 | 7.418 | 0 |
| Shareholders Funds | - | 18.973 | 28.923 | 48.402 | 78.649 | 105.486 | 41.736 | 57.129 | 13.191 | 151 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.629 | 126 | 1.199 | 970 | 1.061 | 964 | 1.658 | 1.696 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mascaş Med S.r.l.